Among them, we found that GOT2 silencing enhances glutamine catabolism, nucleotide synthesis, and glutathione synthesis by reprogramming glutamine metabolism to support the cellular antioxidant system and its activation of the PI3K/AKT/mTOR pathway to promote HCC progression. The gene discussed is GOT2; the disease is hepatocellular carcinoma.